Literature DB >> 32675147

Implementation and outcomes of the RAPID programme: Addressing the front end of the lung cancer pathway in Manchester.

Matthew Evison1, Kath Hewitt2, Judith Lyons2, Phil Crosbie2, Haval Balata2, Caroline Gee2, Rebecca Duerden2, Melanie Greaves2, Anna Sharman2, Richard Booton2.   

Abstract

INTRODUCTION: Patients with suspected lung cancer require computed tomography (CT), specialist interpretation of the CT and a consultation with a specialist. Significant time savings could be made with rapid access to these components in the front end of the lung cancer pathway.
METHODS: The RAPID programme was launched at Manchester's Wythenshawe Hospital in April 2016. This pathway offers next working day CT for patients with suspected lung cancer, immediate 'hot' reporting of CT images and a same day consultation with a diagnostic specialist.
RESULTS: From April 2016 to January 2019, 1,027 patients were referred to the RAPID programme. The median time from referral to CT was 3 days. The CT was hot reported in 94% of patients. The median time from CT to triage and consultation with a diagnostic specialist was 0 days. Overall 56% and 90% of patients had completed a CT and consultation within 3 and 7 days of referral, respectively (0% and 24% prior to implementation).
CONCLUSION: Through simple reorganisation of workload, we have significantly reduced the pathway for patients with suspected lung cancer to meet a specialist with a reported CT, something we firmly believe is replicable across all hospitals. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  Lung cancer; RAPID programme; pathway

Mesh:

Year:  2020        PMID: 32675147      PMCID: PMC7385808          DOI: 10.7861/clinmed.2019-0218

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  4 in total

1.  Variation in lung cancer resources and workload: results from the first national lung cancer organisational audit.

Authors:  K Cusworth; E O'Dowd; R Hubbard; P Beckett; M D Peake; I Woolhouse
Journal:  Thorax       Date:  2015-06-04       Impact factor: 9.139

2.  Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma.

Authors:  Chi-Fu Jeffrey Yang; Hanghang Wang; Arvind Kumar; Xiaofei Wang; Matthew G Hartwig; Thomas A D'Amico; Mark F Berry
Journal:  Chest       Date:  2017-08-08       Impact factor: 9.410

3.  Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival.

Authors:  Daniel R Gomez; Kai-Ping Liao; Stephen G Swisher; George R Blumenschein; Jeremy J Erasmus; Thomas A Buchholz; Sharon H Giordano; Benjamin D Smith
Journal:  Radiother Oncol       Date:  2015-05-23       Impact factor: 6.280

4.  Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial.

Authors:  Neal Navani; Matthew Nankivell; David R Lawrence; Sara Lock; Himender Makker; David R Baldwin; Richard J Stephens; Mahesh K Parmar; Stephen G Spiro; Stephen Morris; Sam M Janes
Journal:  Lancet Respir Med       Date:  2015-02-04       Impact factor: 102.642

  4 in total
  3 in total

1.  When routine bites hard….

Authors:  Anton Emmanuel
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

Review 2.  Lung cancer for the non-respiratory physician.

Authors:  Emma O'Dowd; Joe Mackenzie; Haval Balata
Journal:  Clin Med (Lond)       Date:  2021-11       Impact factor: 2.659

Review 3.  Interventions to improve early cancer diagnosis of symptomatic individuals: a scoping review.

Authors:  George N Okoli; Otto L T Lam; Viraj K Reddy; Leslie Copstein; Nicole Askin; Anubha Prashad; Jennifer Stiff; Satya Rashi Khare; Robyn Leonard; Wasifa Zarin; Andrea C Tricco; Ahmed M Abou-Setta
Journal:  BMJ Open       Date:  2021-11-09       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.